| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Solo Professionals > A Productivity Profile - The Accountant |
|
Advice You - A Productivity Profile - The Accountant
A productivity profile is an overview of some main characteristics of... in this cas According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product e the accountant.
We are all productive but each in a different way and only a few ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in characteristics determine a productivity profile. Think about a profile as a caricat lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ure which is designed around the most striking features of a persons' face. One of here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe the characteristics of an accountant is that you will need him or her (most) at the d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro end of the year. When the business of that particular year is finished and all data ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc is gathered it is up to the accountant to present an overview. Often the overview is easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi there and the accountant checks for inconsistencies. One of the innovations that b nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically rought the Balanced Score Card is that financial results and expectations are not lo and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ nger enough to drive a business. Now is the accountant not responsible for the finan ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ial results, but he is able to influence them. Often, productivity is centered arou ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a nd a product. Even for a marketing campaign you need a product like for example a co dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod mmercial. The productivity role of the accountant however is not associated with a p cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin roduct but is to do with matching the various needs of stakeholders in a business pr tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ocess.
The main stakeholder for the accountant is obviously the company itself (CF t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel O). Yet from incidents like Enron we know that the second stakeholder is the fiscal ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust authority or government, represented by law.
So the main characteristic of the acco y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products unt’s productivity is to find that match that is still acceptable by fiscal laws and . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de optimized for the company’s financial requirements. For more about productivity vi elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip sit:
http://www.astorwhite.com/What_is_my_productivity_profile.php © 2007 Hans Boo tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Self Confidence Building for Job Hunters
|